EMA Authorised: Sildenafil ratiopharm (sildenafil) — Ratiopharm GmbH

View source ↗

Summary

EU authorization for Sildenafil ratiopharm for erectile dysfunction; marketing authorization granted to Ratiopharm GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Sildenafil ratiopharm (sildenafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Ratiopharm GmbH. Decision date: 21/06/2022